Type
1.
Li J, Wang C-H, Yu D-H, He Q, He W. One Case of Tuberculosis-Like Leprosy with a Type I Leprosy Reaction. Clinical, cosmetic and investigational dermatology [Internet]. 2023;16:2517-23. Available from: https://www.dovepress.com/getfile.php?fileID=92847
Type
1.
Fairley JK, Ferreira JA, Fraga LAO, Lyon S, Cardoso TMV, Boson VC, et al. High-Resolution Plasma Metabolomics Identifies Alterations in Fatty Acid, Energy, and Micronutrient Metabolism in Adults across the Leprosy Spectrum. The Journal of infectious diseases. 2023;
Type
1.
Gautam S, Sharma D, Singh S, Arora M, Goel A, Bisht D. Analysis of socioeconomic condition and bacillary index with respect to the development of Hansen’s disease. International journal of mycobacteriology [Internet]. 2023;12(3):254-60. Available from: https://journals.lww.com/ijmy/fulltext/2023/12030/analysis_of_socioeconomic_condition_and_bacillary.6.aspx
Type
1.
Rodriguez-Rivera D V, Del Toro NMP-, Quintero-Noriega AL. Leprosy Reactions: Experience in the Puerto Rico Hansen’s Disease Population. Puerto Rico health sciences journal. 2023;42(3):197-202.
Type
1.
Hansen PY, Myers E, Rajalingam K, Labanowski M. A Rare Case of Hansen’s Disease Complicated by G6PD Deficiency. Cureus [Internet]. 2023;15(8):1-5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471196/pdf/cureus-0015-00000042816.pdf
Type
1.
Spekker O, Tihanyi B, Kis L, Madai Á, Pálfi G, Csuvár-Andrási R, et al. Leprosy: The age-old companion of humans - Re-evaluation and comparative analysis of Avar-period cases with Hansen’s disease from the Danube-Tisza Interfluve, Hungary. Tuberculosis (Edinburgh, Scotland) [Internet]. 2023;142:1-25. Available from: https://www.sciencedirect.com/science/article/pii/S1472979223000914/pdfft?md5=d2df08672ca866946d9e497e37f42d32&pid=1-s2.0-S1472979223000914-main.pdf
Type
1.
Alfredo M de AC, Schmitt JV, Miola AC, Milagres S de P, Lastória JC. Cardiovascular events associated with thalidomide and prednisone in leprosy type 2 reaction. Anais brasileiros de dermatologia [Internet]. 2023; Available from: https://pdf.sciencedirectassets.com/776631/AIP/1-s2.0-S0365059623001939/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEGkaCXVzLWVhc3QtMSJHMEUCIQCC%2FZqGddG1EAq2IIduWgNbdsdsRIDNAoqvzIhXkv7%2BqAIgMk2A85Y60%2FLebIw8Nf54ywCrGZBSxTQaFZJEFmCJQiYqsgUIQRAFGgwwNTk
Type
1.
Monroy B, Sanchez K, Arguello P, Estupiñán J, Bacca J, Correa C V, et al. Automated chronic wounds medical assessment and tracking framework based on deep learning. Computers in biology and medicine. 2023;165.
Type
1.
Serra MAA de O, da Silva RAA, Monari FF, Silva JOE, Junior JX de S, Silva R de AE, et al. Individual, socioeconomic and healthcare access factors influencing the delays in leprosy presentation, diagnosis and treatment: a qualitative study. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2023;
Type
1.
Anderson L, Adelman M, Reinar LM, Dellavalle RP. From the Cochrane Library: Interventions for Ulceration and Other Skin Changes Caused by Nerve Damage in Leprosy. JMIR dermatology [Internet]. 2023;6:1-3. Available from: https://derma.jmir.org/2023/1/e47148/PDF
Pagination
- Previous page
- Page 20
- Next page